Inflammasome Therapeutics: Funding, Investors & Team (Nov 2026)
Inflammasome Therapeutics focuses on creating treatments for common, progressive illnesses such as Alzheimer's disease and Parkinson's disease.
Inflammasome Therapeutics has raised $16.0M across 2 funding rounds on record, the most recent an undisclosed round of $13.2M announced in May 2026.
That round is above the $8.8M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Inflammasome Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Inflammasome Therapeutics Funding Rounds
Inflammasome Therapeutics raised $2.8M in an undisclosed round announced in Aug 2023.
2.8 years later, an undisclosed round of $13.2M was announced in May 2026.
Inflammasome Therapeutics Founders and Leadership Team
Contact details for the Inflammasome Therapeutics team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Inflammasome Therapeutics Funding Compared to Other Biotechnology Startups
Inflammasome Therapeutics' latest round of $13.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Inflammasome Therapeutics in Biotechnology and Newton
Companies Similar to Inflammasome Therapeutics
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…
Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…
Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…
100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Inflammasome Therapeutics Funding FAQs
What does Inflammasome Therapeutics do?
Inflammasome Therapeutics focuses on creating treatments for common, progressive illnesses such as Alzheimer's disease and Parkinson's disease.
How much funding has Inflammasome Therapeutics raised?
Inflammasome Therapeutics has raised $16.0M across 2 rounds on record. The most recent is an undisclosed round of $13.2M announced in May 2026.
When did Inflammasome Therapeutics last raise funding?
Inflammasome Therapeutics' most recent funding round on record is an undisclosed round of $13.2M, announced in May 2026.
Who founded Inflammasome Therapeutics?
FundedIQ lists Jayakrishna Ambati (Founder), Paul Ashton (Founder) at Inflammasome Therapeutics.
Where is Inflammasome Therapeutics headquartered?
Inflammasome Therapeutics is based in Newton, Massachusetts, United States.
How many employees does Inflammasome Therapeutics have?
Inflammasome Therapeutics is in the 1-10 employee band.
How does Inflammasome Therapeutics' funding compare to other Biotechnology startups?
Inflammasome Therapeutics' latest round of $13.2M is above the $8.8M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's Inflammasome Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Inflammasome Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.